awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34250003-FCE6053E-CABB-4F53-B527-8F6F8D0CF921
Q34250003-FCE6053E-CABB-4F53-B527-8F6F8D0CF921
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34250003-FCE6053E-CABB-4F53-B527-8F6F8D0CF921
EGFR biomarkers predict benefit from vandetanib in combination with docetaxel in a randomized phase III study of second-line treatment of patients with advanced non-small cell lung cancer.
P2860
Q34250003-FCE6053E-CABB-4F53-B527-8F6F8D0CF921
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34250003-FCE6053E-CABB-4F53-B527-8F6F8D0CF921
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2441efdfc98d62c53bb87b571ef4df08319a30ba
P2860
Update on epidermal growth factor receptor mutations in non-small cell lung cancer.